Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy

por Kannan, Sankaranarayan, Irwin, Mary E., Herbrich, Shelley M., Cheng, Tiewei, Patterson, LaNisha L., Aitken, Marisa J. L., Bhalla, Kapil, You, M. James, Konopleva, Marina, Zweidler-McKay, Patrick A., Chandra, Joya
Publicado 2022